Hasil Pencarian - Tzu‐Hsiu Tsai

  • Menampilkan 1 - 9 hasil dari 9
Perbaiki Hasil
  1. 1
    Acute Cytomegalovirus Pneumonitis in Patient with Lymphomatoid Granulomatosis

    Acute Cytomegalovirus Pneumonitis in Patient with Lymphomatoid Granulomatosis oleh Shang-Gin Wu, Tzu-Hsiu Tsai, Shang-Ju Wu

    Diterbitkan 2011-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Soft Stethoscope for Detecting Asthma Wheeze in Young Children

    Soft Stethoscope for Detecting Asthma Wheeze in Young Children oleh Chun Yu, Tzu-Hsiu Tsai, Shi-Ing Huang, Chii-Wann Lin

    Diterbitkan 2013-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway

    miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway oleh Yi-Nan Liu, Meng-Feng Tsai, Shang-Gin Wu, Tzu-Hua Chang, Tzu-Hsiu Tsai, Chien-Hung Gow, Hsin-Yi Wang, Jin-Yuan Shih

    Diterbitkan 2020-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    MiR‐503 pleiotropically regulates epithelial‐mesenchymal transition and targets PTK7 to control lung cancer metastasis

    MiR‐503 pleiotropically regulates epithelial‐mesenchymal transition and targets PTK7 to control lung cancer metastasis oleh Tzu‐Hsiu Tsai, Chien‐Hung Gow, Yi‐Nan Liu, Meng‐Feng Tsai, Tzu‐Hua Chang, Shang‐Gin Wu, Min‐Shu Hsieh, Kang‐Yi Su, Jin‐Yuan Shih

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors

    Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors oleh Chun-Ta Huang, Chih-An Lin, Te-Jen Su, Ching-Yao Yang, Tzu-Hsiu Tsai, Chia-Lin Hsu, Wei-Yu Liao, Kuan-Yu Chen, Chao-Chi Ho, Chong-Jen Yu

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer

    Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer oleh Chien-Hung Gow, Yi-Nan Liu, Huei-Ying Li, Min-Shu Hsieh, Shih-Han Chang, Sheng-Ching Luo, Tzu-Hsiu Tsai, Pei-Lung Chen, Meng-Feng Tsai, Jin-Yuan Shih

    Diterbitkan 2018-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinoma

    Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinoma oleh Chia-Ling Chang, Min-Shu Hsieh, Jin-Yuan Shih, Yi-Hsuan Lee, Wei-Yu Liao, Chia-Lin Hsu, Ching-Yao Yang, Kuan-Yu Chen, Jih-Hsiang Lee, Chao-Chi Ho, Tzu-Hsiu Tsai, James Chih-Hsin Yang, Chong-Jen Yu

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first‐line EGFR inhibitor resistance in lung cancer

    Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first‐line EGFR inhibitor resistance in lung cancer oleh Yen‐Ting Lin, Chao‐Chi Ho, Wei‐Hsun Hsu, Wei‐Yu Liao, Ching‐Yao Yang, Chong‐Jen Yu, Tzu‐Hsiu Tsai, James Chih‐Hsin Yang, Shang‐Gin Wu, Chia‐Lin Hsu, Min‐Shu Hsieh, Yen‐Lin Huang, Chia‐Ling Wu, Jin‐Yuan Shih

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC

    Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC oleh Bin-Chi Liao, MD, Wei-Hsun Hsu, MD, Jih-Hsiang Lee, MD, Ching-Yao Yang, MD, PhD, Tzu-Hsiu Tsai, MD, PhD, Wei-Yu Liao, MD, PhD, Chao-Chi Ho, MD, PhD, Chia-Chi Lin, MD, PhD, Jin-Yuan Shih, MD, PhD, Chong-Jen Yu, MD, PhD, Ross A. Soo, M.B.B.S., James Chih-Hsin Yang, MD, PhD

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: